Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus...
Bristol-Myers Squibb Co. (BMY) has a valuation score of 82/100 (strong), profitability score of 82/100 (strong), financial health score of 52/100 (moderate), Piotroski F-Score of 8/9, Altman Z-Score of 1.89 (grey zone), revenue growth of +1.4% YoY.
Neutral
Analyst Consensus
HoldWall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026
Analyst Recommendations35 analysts · 2026-08-01
6
8
19
2
Strong Buy 6Buy 8Hold 19Sell 2Strong Sell 0
Recent Market Moves
See all BMY moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 5 | Regular | $63.73 | -3.28% | -2.19 |
| Aug 5 | After-hours | $63.73 | -3.28% | -2.19 |
| Aug 3 | Pre-market | $67.33 | +3.09% | 2.06 |